VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 112 filers reported holding VISTAGEN THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,646,346 | +30.3% | 13,202,454 | +7.6% | 0.00% | – |
| Q4 2022 | $1,263,601 | -29.0% | 12,267,968 | +4.9% | 0.00% | – |
| Q3 2022 | $1,779,000 | -82.7% | 11,694,556 | -0.2% | 0.00% | – |
| Q2 2022 | $10,311,000 | -29.1% | 11,716,039 | -0.1% | 0.00% | – |
| Q1 2022 | $14,549,000 | -37.3% | 11,732,424 | -1.4% | 0.00% | -100.0% |
| Q4 2021 | $23,193,000 | -28.0% | 11,894,193 | +1.2% | 0.00% | 0.0% |
| Q3 2021 | $32,191,000 | -12.3% | 11,748,472 | +0.8% | 0.00% | 0.0% |
| Q2 2021 | $36,697,000 | +549.2% | 11,650,018 | +339.0% | 0.00% | – |
| Q1 2021 | $5,653,000 | +8465.2% | 2,653,597 | +7654.3% | 0.00% | – |
| Q4 2020 | $66,000 | +187.0% | 34,221 | +3.9% | 0.00% | – |
| Q3 2020 | $23,000 | +35.3% | 32,946 | +0.0% | 0.00% | – |
| Q2 2020 | $17,000 | +13.3% | 32,931 | -4.5% | 0.00% | – |
| Q1 2020 | $15,000 | -31.8% | 34,481 | +9.0% | 0.00% | – |
| Q4 2019 | $22,000 | – | 31,631 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 11,728,033 | $36,943,000 | 14.76% |
| VR Adviser, LLC | 16,047,286 | $50,549,000 | 6.13% |
| COMMODORE CAPITAL LP | 3,331,315 | $10,494,000 | 3.66% |
| Ghost Tree Capital, LLC | 2,000,000 | $6,300,000 | 1.73% |
| EPIQ PARTNERS, LLC | 932,956 | $2,939,000 | 1.47% |
| SPHERA FUNDS MANAGEMENT LTD. | 4,080,673 | $12,854,000 | 0.87% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 615,547 | $1,939,000 | 0.86% |
| HighVista Strategies LLC | 308,096 | $971,000 | 0.69% |
| NEA Management Company, LLC | 16,302,596 | $51,353,000 | 0.67% |
| Nicholas Investment Partners, LP | 2,753,880 | $8,675,000 | 0.54% |